Secondary Logo

Journal Logo

November 2008 - Volume 23 - Issue 6
pp: 305-363,i-iii

Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75–225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study

Kornstein, Susan G.; Kocsis, James H.; Ahmed, Saeeduddin; More

International Clinical Psychopharmacology. 23(6):357-363, November 2008.

PDF Only

PDF Only